Last reviewed · How we verify

NCT06326229

Clinical Validation of Musculoskeletal ICF Core Set in Primary Care Physiotherapy

Recruiting now Last updated 27 June 2024
What this trial tests

trial testing ICF entities assessment in Musculoskeletal Diseases in 385 participants. Currently enrolling.

Timeline
17 June 2024
Primary endpoint
31 January 2025
26 September 2025

Quick facts

Lead sponsorUniversity of Valladolid
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment385
Start date17 June 2024
Primary completion31 January 2025
Estimated completion26 September 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Valladolid

Who can join

Adults 18 to 99, any sex, with Musculoskeletal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study is to validate the content of a tailored ICF core set for the management of musculoskeletal conditions in primary care physiotherapy services. The main question it aims to answer is: \- Are the ICF entities included in the ICF Core Set under evaluation useful from a clinical point of view? Participants will evaluate the relevance of each ICF entity included in the ICF core set according to their musculoskeletal condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Musculoskeletal Diseases

Currently open trials in the same condition.

Other University of Valladolid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06326229.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing